Home › Sports Cardiology, Exercise & Occupational Considerations › Cardiac Screening Cost-Effectiveness Model (Population-Level)

Cardiac Screening Cost-Effectiveness Model (Population-Level)

  • Population size (N)
  • Prevalence of high-risk individuals (%)
  • Screening test sensitivity (%)
  • Screening test specificity (%)
  • Screening test cost per person
  • Confirmatory test cost per positive screen
  • Annual treatment cost per true positive
  • Treatment duration / time horizon (years)
  • Annual baseline event risk in high-risk group (% per year)
  • Relative risk reduction with treatment (%)
  • Acute care cost per cardiovascular event
  • QALY loss per event
  • Discount rate (% per year)
  • Willingness-to-pay threshold per QALY
  • Cardiac Screening Cost-Effectiveness Model (Population-Level): Explanation and Clinical Context
    This calculator implements a population-level cost-effectiveness framework to evaluate cardiac screening programs that identify high-risk individuals and initiate preventive therapy. Users input epidemiologic parameters, screening performance, and cost/QALY data to estimate ICER, QALY gains, and total costs. The model applies reference-case conventions and allows rapid scenario testing for cardiac risk screening strategies.

    Reference:
    Sanders GD, et al. Recommendations of the Second Panel on Cost-Effectiveness in Health and Medicine. JAMA. 2016;316(10):1093–1103.
    Drummond MF, et al. Methods for the Economic Evaluation of Health Care Programmes. 4th ed. Oxford University Press; 2015.
    Wilson JMG, Jungner G. Principles and Practice of Screening for Disease. WHO; 1968.

Create Note

Notes are stored privately on your device only. No login required. Nothing is uploaded or shared.

My Notes

Report this Tool

Appcardio may contain errors. Always verify the calculation and its accuracy before clinical use.